Aclarion Reports 141% YoY Scan Volume Growth in H1 2026

Aclarion, Inc. announced significant operational and strategic progress in the first half of 2026, highlighted by a 141% year-over-year increase in scan volume and 71% sequential growth. The company expanded reimbursement in the U.K. and launched a U.S. Market Access Program to secure insurance coverage for Nociscan. Aclarion also strengthened its intellectual property with a new AI patent, bringing its total to 65 worldwide, and reported a strong cash position of $16.3 million with no debt, providing a cash runway into the second half of 2027.